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Summary 
We generated mice with a null mutation of the fore- 
brain-restricted transcription factor BF-1 to examine 
its function in brain development. Heterozygous ani- 
mals have an apparently normal phenotype. Homozy- 
gous null BF-1 mutants die at birth and have a dramatic 
reduction in the size of the cerebral hemispheres. The 
development of the ventral telencephalon is more se- 
verely affected than that of the dorsal telencephalon. 
Telencephalic neuroepithelial cells are specified in the 
BF-1 mutant, but their proliferation is reduced. Dorsal 
telencephalic neuroepithelial cells also differentiate 
prematurely, leading to early depletion of the progeni- 
tor population. These results suggest that BF-1 con- 
trols the morphogenesis of the telencephalon by regu- 
lating the rate of neuroepithelial cell proliferation and 
the timing of neuronal differenUation. 
Introduction 
The capacity of the mammalian ~rain to perform complex 
tasks depends on the activity of a large number of neurons 
and neuronal cell types that are organized into numerous 
regions specialized for distinct functions. All of the cells 
of the CNS arise from the neuroepithelium, a morphologi- 
cally uniform sheet of cells that folds to form the neural 
tube. Patterning of the neuroepithelium along the antero- 
posterior axis leads to the progressive subdivision of the 
neural tube into regions with distinct fates (Keynes and 
Lumsden, 1990). Families of regulatory genes with re- 
stricted patterns of expression within the neuroepithelium 
have been identified that are believed to function to estab- 
lish positional identity in the neuroepitheliu mand to control 
region-specific morphogenesis of the brain (Krumlauf et 
al., 1993; Figdor and Stern, 1993; Puelles and Rubenstein, 
1993). The telencephalon gives rise to the structures of 
the cerebral hemispheres, which include the cerebral cor- 
tex and the basal ganglia. While several regulatory gene 
families have been recently described with expression 
boundaries within the telencephalic neuroepithelium, in- 
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cluding Otx, Emx, DIx, and Pax genes (Simeone et al., 
1992; Porteus et al., 1991; Price et al., 1991; Chalepakis 
et al., 1993), the mechanisms controlling the development 
of this largest and most complex region of the brain re- 
main the least well understood. One of the striking fea- 
tures of mammalian telencephalon development is its in- 
creased and prolonged growth relative to the other regions 
of the neural tube. This relative expansion of the cerebral 
hemispheres is an important component of vertebrate vo- 
lution. Encephalization of the brain is most prominent in 
mammals, particularly in primates, and is associated with 
the acquisition of higher cognitive functions (Hofman, 
1989). Very little is presently known about the molecular 
mechanisms that control either the specification or the 
growth of the telencephalon. 
We have previously identified brain factors 1 and 2 (BF-1 
and BF-2, respectively), two new members of the winged 
helix (WH) family of transcription factors. The members 
of this gene family share a DNA binding domain, first identi- 
fied in the HNF-3 proteins (Lai et al., 1990, 1991). This 
domain has been called the winged helix based on its 
three-dimensional structure determined by X-ray diffrac- 
tion of an H NF-3"y/DNA cocrystal (Clark et al., 1993). Many 
WH genes have been shown to play critical roles during 
development (reviewed in Lai et al., 1993). BF-1 expres- 
sion in the developing brain is restricted to the telence- 
phalic neuroepithelium and the nasal half of the retina and 
optic stalk, its expression domain is adjacent to that of 
BF-2, which is restricted to the rostral diencephalon and 
the temporal half of the retina and optic stalk (Tao and 
Lai, 1992; Hatini et al., 1994). BF-1 is detected in the neu- 
roepithelium prior to the morphological appearance of the 
telencephalon-diencephalon boundary, suggesting a role 
in patterning the forebrain. Expression levels of BF-1 are 
highest in the rapidly proliferating cells of the neuroepithel- 
ium, declining as the cells become postmitotic. Further 
evidence for a role for BF-1 in growth control is suggested 
by the identification ofan oncogene from an avian sarcoma 
virus, qin, as the chicken homolog of BF-1 (Li and Vogt, 
1993). From these observations, we postulated that BF-1 
may function to specify the positional identity of the telen- 
cephalic neuroepithelium and to determine its proliferative 
potential during brain development (Hatini et al., 1994). 
To examine the function of BF-1 in brain development, 
we generated mice with a null mutation in the BF-1 gene. 
Deletion of both copies of BF-1 leads to a marked reduction 
in the size of the cerebral hemispheres. The growth of the 
ventral telencephalon is more severely affected than that 
of the dorsal telencephalon. We demonstrate a reduction 
in the proliferation rate of the dorsal and ventral telence- 
phalic neuroepithelium as well as alterations in the timing 
of neuronal differentiation i the cerebral cortical neuroepi- 
thelium. These findings establish an essential role for BF-1 
in forebrain development and suggest that it may function 
in the developmental control of cell proliferation and neu- 
ronal differentiation. 
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Figure 1. Targeted Disruption of the BF-1 Gene and Resulting Brain Phenotype 
(A) Targeting vector. Nearly all of the coding sequence of BF-1 was deleted by removal of a 2.3 kb fragment in the genomic DNA. The lacZ 
sequence with a nuclear localization signal was fused in-frame with the first 13 amino acids of BF-1 to express functional I~-galactosidase (13-gal) 
under the control of the BF-1 promoter. B, BamHI; K, Kpnl; N, Ndel; S, Sail; Sf, Sill; Sm, Smal. 
(B) PCR analysis of a typical litter to genotype the offspring of heterozygote matings. Two sets of primers were used to identify the presence of 
lacZ (822 bp band) or the BF-1 sequences (295 bp band) in genomic DNA from a typical litter. The absence of a PCR product using the BF-1 
primers confirms that these sequences are deleted in the BF-1 homozygote. 
(C) Southern analysis of littermates from a heterozygote mating to confirm the genotype of animals identified initially by PCR. The probe shown 
in (A) hybridizes to genomic fragments generated by the restriction endonucleases BamHI (11 and 14 kb) and Kpnl (6 and 9 kb). 
(D) Brains dissected from newborn wild-type (WT) and BF-1 mutant (BF-1 +)  littermates: dorsal (upper pair) and ventral (lower pair) views. The 
mutant brain has markedly reduced cerebral hemispheres (arrowheads) that rest on the dorsolateral surface of the diencephalon. The remainder 
of the brain appears normal in the mutant, c, cerebral hemisphere; d, diencephalon; h, hindbrain; m, midbrain. Bar, 1 mm. 
Results 
Generation of a Null Mutation in BF-1 
A null mutation of BF-1 was generated by replacing most 
of the coding sequence of BF-1, which is contained in a 
single exon, with a lacZ and neomycin cassette (Figure 
1A). The 13-galactosidase (l~-gal) sequence containing a 
nuclear localization signal was fused in-frame to the first 
13 amino acids of BF-1, with the goal of placing the expres- 
sion of this enzyme under the control of the BF-1 promoter 
and the BF-1 translation initiation site. Electroporated em- 
bryonic stem (ES) cells (C J7 and J1 lines) integrating the 
targeting construct were selected for drug resistance with 
G418. Cells undergoing homologous recombination were 
identified initially by the polymerase chain reaction (PCR) 
and Confirmed by genomic Southern analysis (Figures 1 B 
and 1C). Correctly targeted ES cells were injected into 
C57BL/6J host blastocysts o generate chimeric mice. Chi- 
meric males from I clone each of ES cells from CJ7 and J1 
lines transmitted the targeted DNA through t e germline, 
generating mice that were heterozygous for the BF-1 dele- 
tion. Heterozygotes are fertile and indistinguishable from 
wild-type littermates, except by the expression of 13-gal. 
Matings between heterozygotes yielded live homozygous 
offspring when pregnant mothers were observed during 
delivery (Table 1). These newborn animals were flaccid 
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Table 1. Genotype of Offspring from BF-1 (+/-) 
Heterozygote Matings 
Genotype 
Age Litters Animals (+/+) (+/-) (-/-) 
E8.5 1 7 1 3 3 
E9.5 7 50 9 26 15 
E 10.5 12 59 23 56 18 
Ell.5 5 45 8 25 12 
E12.5 20 112 41 63 31 
E14.5 1 9 2 4 3 
E16.5 2 10 2 4 4 
E18.5 4 30 11 9 10 
P0 7 53 15 27 11 
Total (E8.5-birth) 59 436 112 217 107 
(26%) (50%) (24o/o) 
>P1 5 36 11 25 0 
(31%) (69°/0) (0%) 
Homozygous BF-1 mutants survive to term. P0 indicates litters for 
which delivery was observed. All of the homozygous mutants were 
born alive, but they all died within 20 rain of birth. 
and displayed minimal spontaneous movement except for 
intermittent gasping motions. All of them remained cya- 
notic and died within minutes after birth. At autopsy, the 
alveoli of the lungs were uninflated (data not shown), dem- 
onstrating that death was due to respiratory failure, al- 
though the exact cause remains unclear. Homozygous 
BF-1 mutant animals derived from targeted CJ7 and J1 
ES cells have the same phenotype. The studies presented 
are from CJ7-derived animals. 
BF-1 (- I -)  Mutants Have Small 
Cerebral Hemispheres 
Newborn BF-1 ( - / - )  mutants were distinguishable from 
wild-type and heterozygous littermates by a flattening of 
the frontal skull and by abnormalities of the eyes. Examina- 
tion of the newborn brain showed that the cerebral hemi- 
spheres were reduced by 95°/0 in mass (Figure 1D). While 
the cerebral hemispheres normally grow to surround the 
diencephalon, the diminutive mutant cerebral hemi- 
spheres of the BF-1 mutant rest on the dorsolateral surface 
~ii~i ¸ ~ 
Figure 2. Expression of J3-gal in Whole-Mount Embryos Reveals a Progressive Reduction in theSize of the Telencephalic Vesicles and Abnormalities 
of the Eyes 
Detection of ~-gal was done by X-Gal histochemistry. Pairs of embryos are shown with the mutant (-/-) on the left and the heterozygote (+/-) on 
the right at E9.5 (A), E10.5 (B), and E12.5 (C). High power views of the eye regions in the mutant (D) and heterozygous (E) embryos shown in 
(B) are also shown. The ~-gal staining identifies structures that normally express BF-1. In (A)-(C), arrowheads point to the telencephalic vesicles 
of each embryo. While at Eg.5 there are only minimal differences in the size of the telencephalic vesicles between the mutant and heterozygote 
(A), the growth of the vesicles in the mutant is progressively retarded relative to th  heterozygote at E10.5 (B)and E12.5 (C). The surface of the 
telencephalic vesicles is also irregular in the E 12.5 mutant. Prominent in the mutant eye is the wavy appearance of the anterior retinal neuroepitheliu m 
(D and E, arrowheads) as well as the ventral rotation of the entire eye. Bars, 200 t m (A), 400 tam (B and C), 100 tam (D and E). 
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Figure 3. Development of the Ventral Telencephalon Is More Severely Affected Than That of t e Dorsal Teiencephalon in the BF-1 Mutant 
Expression of ~-gal identifies structures derived from the telencephalon in E12.5 BF-1 (4/-) heterozygotes and BF-1 (-/-) mutants ([A and B] 
sagittal views; [C and D] coronal views). Expression patterns of markers for the dorsal telsncephalon, Emx2 (E-H) and Pax6 (I and J), and for 
the ventral telencephalon, DIx2 (K and L), were analyzed by in situ hybridization in wild-type (WT) and mutant (BF-1 +) E12.5 embryos. Sections 
were matched to show comparable structures in each pair, Horizontal views sho  the expression of Emx2 in the telencephalic vesicles of both 
wild-type (E) and mutant (F) embryos. Coronal sections at a level anterior to the eyes show the telencephalic vesicles and the ganglionic eminences 
in wild-type embryos (G and I). Both Emx2 and Pax6 are restricted to structures derived from the dorsal talencephalon. The mutant dorsal 
telencephalon extends more ventrally and medially than normal, as demonstrated by the expression pattern of both Emx2 (H) and Pax6 (J). The 
small region of the ventral telencephalic neuroepithelium (indicated by arrowheads) that does not express either dorsal or ventral markers most 
likely represents vestigial ventral telencephalic neuroepithelium. Horizontal views at a more ventral level than those in (E) and (F) show the ganglionic 
eminences in wild-type embryos (K), which, along with the diencephalic neuroepithelium, express DIx2. Expression of DIx;?. in the mutant is confined 
to the diencephalon (L). Embryos are from two litters, nominally at E12.5; however those in (A)-(D) are smaller and younger than those in (E)- 
(L). d, diencephalon; fg, foregut; ge, ganglionic eminence; ne, nasal epithelium; rp, Rathke's pouch; tv, telencephalic vesicles. Bars, 400 I~m (A 
and B), 200 p.m (C-L). 
of the diencephalon. The olfactory bulbs were also mark- 
edly reduced in size. The remainder of the brain appeared 
normal by gross inspection in the newborn and by light micro- 
scopy in midgestation embryos (E10.5-E14.5). Whole- 
mount heterozygous embryos stained for 13-gal activity 
showed that the staining pattern matched closely the nor- 
mal pattern of BF-1 RNA expression detected by in situ 
hybridization. 13-gal expression in the BF-1 ( - / - )  homozy- 
gous mutant was also detected in the same tissues, which 
permitted us to identify tissues in which BF-1 would have 
been expressed if the gene had not been deleted (Figure 
2). BF-1 is first detected in the neural tube between E8.5 
and E9.0. At E9.5, heterozygous and mutant embryos dis- 
played minimal differences in the size of the telencephalic 
vesicles, which have just begun to form (Figure 2A). Differ- 
ences in the size of the vesicles at this age are associated 
with the small variation in the developmental stage of em- 
bryos within a litter rather than with a clear abnormality 
in the BF-1 mutant. By E10.5, however, the telencephalic 
vesicles in the homozygous mutant were distinctly smaller 
than those in heterozygotes (Figure 2B). A further reduc- 
tion in the size of the telencephalic vesicles of the mutant 
relative to the heterozygote was apparent in E12.5 em- 
bryos (Figure 2C). In addition to the small size, the normal 
uniform and smooth appearance of the developing cere- 
bral cortex was replaced in the BF-1 mutant with an irregu- 
lar, uneven appearance. This was due both to buckling 
of the neuroepithelium and to variations in the thickness 
of the cortical tissue (see below). Thus, the telencephalon 
initially appeared to be formed normally in the BF-1 mu- 
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tant. Differences between mutant and wild-type mbryos 
became progressively more apparent as development pro- 
ceeded. 
The eyes of newborn BF-1 ( - i - )  mutant animals were 
distorted in shape, being ellipsoid instead of round. Irregu- 
larities in the contour of the retina were apparent, most 
prominently in the nasal retina (compare Figures 2D and 
2E). The development of nasal structures arising from the 
nasal placode was also affected in the BF-1 mutant. While 
the nasal placodes of the heterozygote and mutant homo- 
zygote are comparable at E9.5 (Figure 2A), the mutant 
nasal placodes and the nasal epithelium arising from them 
fail to grow normally (Figures 2B-2E; Figure 3D). Further 
studies are in progress to examine the mechanisms that 
underlie these developmental defects. In contrast, the 
structures arising from the otic vesicle, pharyngeal 
pouches and Rathke's pouch (e.g., the inner ear, the ante- 
rior foregut, and the pituitary), were not appreciably af- 
fected in the BF-1 mutant (Figure 2; Figure 3; and data not 
shown). Additional analyses will be required to determine 
whether there are subtle anomalies of these structures in 
the BF-1 mutant. 
Failure of the Ventral Telencephalon to Grow 
in BF-1 ( - / - )  Mutants 
Further examination of the brain of the BF-1 (-/-) mutant 
revealed that the development of the ventral telencepha- 
Ion is more severely affected than that of the dorsal telen- 
cephalon. The cerebral cortex is the major structure to 
develop from the dorsal telencephalon, while most of the 
ventral telencephalon will give rise to the ganglionic emi- 
nences that are the primordia of the basal ganglia. Nor- 
mally, the ventral telencephalon expands dramatically 
between E9.5 and E12.5. During this period, ventral telen- 
cephalic neuroepithelial cells proliferate rapidly and begin 
to differentiate. Postmitotic neurons migrate outward from 
the ventricular zone to form the ganglionic eminences. The 
expansion of the ventral telencephalon ormally displaces 
the telencephalic vesicles laterally and dorsally (Figures 
3A, 3C, 3G, 31, and 3K). At F12.5 in the BF-1 mutant, the 
ganglionic eminences were not present (Figures 3B, 3D, 
3H, and 3J). Sagittal and coronal views showed only a 
thin neuroepithelium in their place (Figure 3, arrowheads), 
which expressed 13-gal thus confirming its telencephalic 
origin (Figure 3D). The dorsal telencephalic vesicles of the 
BF-1 mutant are positioned more ventrally and closer to 
the level of the eyes than the corresponding structures of 
wild-type embryos. These observations suggest that, 
while the dorsal telencephalon of the BF-1 mutant is re- 
duced in size, the ventral telencephalon is almost com- 
pletely absent. 
In situ hybridization studies examining the expression 
patterns of the dorsal telencephalic markers Emxl, Emx2 
(Simeone et al., 1993), and Pax5 (Walther and Gruss, 
1991) as well as the ventral telencephalic markers Dlxl 
and DIx2 (Porteus et al., 1991; Price et al., 1991) further 
support this conclusion. We found that almost all of the 
telencephalic neuroepithelium at E12.5 in the BF-1 mutant 
expressed the dorsal markers Emx2 (Figures 3F and 3H), 
Pax6 (Figure 3J), and Emxl (data not shown). Neither 
ventral marker, DIx2 (Figu re 3L) and DIx 1 (data not shown), 
was detectable in these tissues. In younger embryos, the 
thicknesses of the dorsal and ventral regions of the neu- 
roepithelium were more comparable than at E12.5. At 
E10.5, the expression domain of dorsal markers also ex- 
tended more ventrally in the mutant (Figures 4C and 4D), 
while ventral markers were not detected (data not shown). 
Thus, most of the small, distorted telencephalic tissues 
found in the BF-1 mutant embryos are dorsal structures 
representing primarily the developing cerebral cortex. The 
tissue that expressed the ~-gal marker (Figures 3B and 
3D, arrowheads) but was negative for the expression of 
the dorsal telencephalic markers, Emx2 (Figu re 3H; Figure 
4D) and Pax6 (Figure 3J), we believe to be the vestigial 
ventral telencephalic neuroepithelium. However, because 
we did not detect the expression of Dlxl or DIx2 in these 
cells (Figure 3L), it remains possible that ventral specifica- 
tion is abnormal in these nondorsal telencephalic cells. 
Reduced Proliferation of the Telencephalic 
Neuroepithelium in BF-1 ( - / - )  Mutants 
Failure of the telencephalon to grow normally in the BF-1 
mutant could be due to several mechanisms, including a 
reduction in the rate of proliferation of the neuroepithelial 
precursors, a reduction in the fraction of cells that continue 
to divide, or an increase in the rate of cell death or 
apoptosis. No significant differences in apoptosis, as de- 
termined by the number of pyknotic nuclei, were observed 
in the forebrain of BF-1 homozygous mutant or wild-type 
embryos (data not shown). This suggested that increased 
cell death is unlikely to be the primary reason for the small 
size of the telencephalon in the BF-1 mutant. We therefore 
studied the effect of the BF-1 deletion on the proliferation 
and differentiation of the neuroepithelial cells of the telen- 
cephalon. Cell proliferation in the neuroepithelium was 
examined by bromodeoxyuridine (BrdU) labeling. BrdU is 
incorporated into cells in S phase. The fraction of cells 
labeled with BrdU during a short pulse reflects the fraction 
of cells in S phase during this period, permitting an assess- 
ment of the proliferation rate of a population of ceils (Grat- 
zner, 1982). No significant differences were observed in 
the BrdU labeling patterns of mutant and wild-type em- 
bryos at E9.5 (data not shown). Differences in BrdU label- 
ing of the telencephalic neuroapithelium become apparent 
only later in development, corresponding to the progres- 
sively greater differences in the size of the telencephalon 
between mutant and wild-type embryos after E9.5. In coro- 
nal sections of E10.5, we used lacZ expression to identify 
the telencephalon (data not shown) and Emx2 as a marker 
of dorsal telencephalon (Figures 4C and 4D). The identity 
of the ventral telencephalon was also confirmed morpho- 
logically in wild-type embryos by the increased thickness 
of the developing ganglionic eminences (Figures 4A and 
4C, arrowheads). The fraction of BrdU-labeled cells was 
uniformly high in both dorsal and ventral regions of the 
wild-type telencephalon (Figures 4A and 4E). BrdU label- 
ing in the E10.5 mutant revealed a clear difference be- 
tween the dorsal and ventral regions of the telencephalon. 
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Figure 4. Reduced Cell Proliferation in the 
Ventral Telencephalic Neuroepithelium of the 
BF-1 Mutant 
Proliferative activity in the telencephalic neu- 
roepithelium ofE10.5 wild-type (WT) and mu- 
tant (BF-1 -~-) animals was detected by BrdU 
immunohistochemistry (A, B, E, and F). All sec- 
tions are in the coronal plane just anterior to 
the optic vesicles. Adjacent sections were pro- 
cessed for in situ hybridization with a dorsal 
marker, Emx2, to define the boundary be- 
tween dorsal and ventral telencephalon (C and 
D). The dorsal telencephalon as marked by 
Emx2 is positioned more lateral nd ventral in 
the mutant. (E) and (F) show high power views 
of the dorsal-ventral boundary region deline- 
ated in (A) and (B), respectively. Arrowheads 
indicate the ventral telencephalon. Bar, 120 
p.m (A-D), 40 p~m (E and F). 
Quantitation of these results is presented in Table 2. These 
data show a 79% reduction in the proliferative activity of 
the precursor cells in this region. Thus, in the E10.5 BF-1 
mutant, only the dorsal telencephalic neuroepithelial cells, 
which express Emx2, are actively proliferating. These re- 
sults suggest that the absence of the ventral telencepha- 
Ion in the BF-1 mutant is due primarily to the failure of 
the precursor cells in this region to continue proliferating 
actively after 1=9.5. 
In the dorsal telencephalic neuroepithelium, the differ- 
ences in the BrdU labeling pattern between wild-type and 
BF-1 mutant embryos were more subtle and became ap- 
parent later in development. The fraction of BrdU-labeled 
cells throughout he telencephalic neuroepithelium was 
uniform in wild-type mbryos at E12.5 (Figure 5A). In BF-1 
mutants at E12.5, there were significant variations in the 
fraction of BrdU-labeled cells within the dorsal telence- 
phalic neuroepithelium, most notably a 2-fold difference 
between anterior and posterior egions (Figure 5B; Table 
2). Thus, at least part of the reduction in the growth of the 
dorsal telencephalon in the BF-1 mutant is attributable to 
areas of reduced proliferation within the rteuroepithelium. 
We also observe a buckling of the ventricular surface at 
the boundary between areas with different fractions of 
BrdU-labeled cells, and therefore different rates of cell 
proliferation (Figure 5B). This suggests that some of the 
irregularities in the cerebral cortex of the BF-1 mutant arise 
from the nonuniform rates of cell proliferation within the 
neuroepithelium. These studies do not distinguish be- 
tween a lengthening of the cell cycle and an increase in 
the fraction of the cells that have left the cell cycle as the 
basis for the decreased rate of cell proliferation. 
The similar morphology and the comparable BrdU label- 
ing patterns of mutant, heterozygous, and wild-type em- 
bryos at E9.5 suggest that cell proliferation in the telence- 
phalic neuroepithelium is initially independent of BF-I. 
However, the proliferation of the ventral telencephalic neu- 
roepithelium in the BF-1 mutant is reduced progressively 
such that this region stops growing by E10.5. Abnormali- 
ties in the proliferation of the dorsal telencephalic neuro- 
epithelium also become more severe as development pro- 
ceeds. 
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Table 2. BrdU Labeling in the Telencephalic Neuroepithelium 
Percentage of BrdU Labeling 
_+ SEM 
Wild Type BF-1 (-/-) 
E10.5 coronal section 
Dorsal 45 _+ 2 42 _ 2 
Ventral 41 _+ 1 9 _ 1 
E12.5 horizontal section 
Anterior 43 _+ 2 25 _+ 8 
Posterior 47 _+ 3 46 _+ 3 
Embryos were pulse labeled with BrdU ~.nd stained by immunohisto- 
chemistry as described in Experimental Procedures. Nuclei were 
counted under a Zeiss Axioplan light microscope equipped with a retic- 
ular eyepiece, in units of neuroepithelium 100 pm in length. Represen- 
tative areas demonstrating differences in the BF-1 mutant were chosen 
for counting, as were comparable areas in the wild type. The fraction of 
BrdU-labeled cells was determined by ividing the number of positive 
nuclei (brown) by the total number of nuclei. Groups of 2-3 consecutive 
tissue sections from the same animals were used. For the dorsal- 
ventral differences at E10.5, wild-type data were pooled from a total 
of 18 sections from three embryos, while the mutant data was pooled 
from a total of 22 sections from four embryos. For the anterior-posterior 
differences fround in E12.5 dorsal telencephalon, both wild-type and 
mutant data were obtained from 9 sections fr m three embryos. Data 
are expressed as the mean _+ SEM. 
Premature Onset of Neuronal Differentiation 
in BF-1 ( - / - )  Mutants 
The major period of cerebral cortical neuronal differentia- 
tion in the mouse occurs between E11 and E18 (Caviness 
and Sidman, 1973). The neuroepithelium or theventricular 
zone is comprised of mitotically active progenitor cells and 
is the source of all neurons and glia in the adult cerebral 
cortex. Prior to E l l ,  essentially all of the neuroepithelial 
cells are actively dividing. As development progresses, 
an increasing proportion of the neuroepithelial cells start 
to exit the cell cycle, begin to differentiate, and migrate 
away from the ve ntricular zone to populate the layers of the 
cortex (Angevine and Sidman, 1961 ; Berry et al., 1964). At 
the beginning of this period of neurogenesis, the neuroepi- 
thelium comprises nearly the entire thickness of the cere- 
bral cortex. Only the preplate neurons, which are the ear- 
liest to be born, are present on the outer surface of the 
ventricular zone (Marin-Padilla, 1990). Gradually, the 
thickness of the cortical plate increases as more cells 
leave the neuroepithelium and migrate outward. 
The cerebral cortex of the BF-1 mutant was observed 
to vary in thickness compared with the uniform appear- 
ance of the wild-type cerebral cortex. By clearly delineat- 
WT BF_I-/- Figure 5. Reduced Cell Proliferation i the Dorsal Telencephalic Neuroepithelium is Ac- 
companied by Early Onset of Neuronal Differ- 
entiation in the BF-1 Mutant 
Adjacent horizontal sections at the level of the 
neocortex in wild-type animals were processed 
for immunodetection of BrdU (A and B) and 
MAP2 (C and D) to determine the proliferative 
activity and the pattern of neuronal differentia- 
tion, respectively, in E12.5 animals. The ratio 
of BrdU-labeled cells i  uniform in the wild-type 
(WT) neuroepithelium (A), whereas in the mu- 
tant (BF-I+), there is an anterior region of low 
proliferation (arrowheads) adjacent to a poste- 
rior region with a higher fraction of labeling (B). 
Note the buckling of the surface of the neuro- 
epithelium at the boundary between these two 
regions. In the wild-type cerebral cortex, the 
early differentiating neurons, as demonstrated 
by MAP2 labeling, are restricted to the narrow 
preplate layer (C, arrowhead). In the mutant, 
cells outside of the ventricular zone (asterisk) 
are greatly increased in proportion to those 
within it. These cells are present both anteriorly 
and posteriorly and are MAP2-positive (D, ar- 
rowheads), vz, ventricular zone. Bar, 100 i~m. 
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ing the neuroepithelium, BrdU labeling also revealed that 
this was due to an increase in the fraction of cells outside 
the ventricular zone. Whereas the ventricular zone com- 
prised nearly all of the cerebral cortical tissue in wild-type 
E12.5 embryos, it appeared to make up a smaller fraction 
of the cortical tissue in the BF-1 mutant. In some areas 
of the mutant cerebral cortex at E 12.5, the ventricular zone 
represented less than one-quarter of the thickness of the 
cortical tissue. This difference was due mainly to an in- 
crease in the number of cells outside of the ventricular 
zone (Figure 5B, asterisk). To determine whether these 
cells were differentiating neurons, we used a marker of 
early postmitotic neurons, microtubule-associated protein 
2 (MAP2; Crandall et al., 1986), and compared its expres- 
sion in wild-type and mutant embryos. 
In normal cerebral cortex at E12.5, MAP2 expression 
was detected only in the preplate neurons (Figure 5C). 
The increased fraction of cells in the BF-1 mutant embryo 
that were outside of the ventricular zone all expressed 
MAP2 (Figure 5D). These MAP2-positive cells did not label 
with BrdU, suggesting that they were postmitotic cells 
committed to neuronal differentiation. The expression of 
the dorsal markers Emxl and Emx2 in these structures 
argues against the possibility that the BF-1 mutation 
causes a transformation of the dorsal telencephalon to a 
more ventral fate. Rather, the data suggest that the BF-1 
deletion results in the early withdrawal of telencephalic 
neuroepithelial cells from the cell cycle and in the prema- 
ture onset of neuronal differentiation. Because most of 
these postmitotic ells migrate away from the ventricular 
zone, the fraction of BrdU-labeled cells in the neuroepithel- 
ium remained unchanged, even though the fraction of cells 
apparently exiting the cell cycle increased. This is most 
obvious in the posterior egion of the BF-1 mutant cerebral 
cortical neuroepithelium, where there was extensive ex- 
pression of MAP2 (Figures 5B and 5D). We suggest that 
these events result in the depletion of progenitor cells at 
an earlier stage in development, leading to a smaller num- 
ber of cells that are ultimately generated in the dorsal telen- 
cephalon. 
Discussion. 
BF-1 and the Development of the 
Cerebral Hemispheres 
BF-1 function is required for the normal development of 
the telencephalon. Two features of the BF-1 null mutant 
phenotype provide unique insights into the mechanisms 
controlling the regional subdivision of the forebrain and 
the differential growth of regions within the telencephalon. 
In prior analyses of targeted deletions that result in devel- 
opmental anomalies of the brain, it has often been difficult 
to distinguish between defects in cell specification and 
cell proliferation (Thomas and Capecchi, 1990; Joyner et 
al., 1991; McMahon et al., 1992). We are able to address 
this issue in the BF-1 mutant because of both the ~-gal 
expression marker and the partial development of the ce- 
rebral hemispheres. The telencephalic neuroepithelium in
both BF-1 heterozygotes and mutant homozygotes can 
be identified by the expression of 13-gal activity and by its 
morphology in early embryos. At E9.5, minimal differences 
in the telencephalic neuroepithelium are apparent be- 
tween heterozygotes and mutants. As development prog- 
resses, tissues in which the BF-1 promoter is active remain 
clearly demarcated in both the heterozygote and the mu- 
tant, despite differences in the size of these structures. 
Even the ventral region that fails to grow can be identified 
as telencephalic neuroepithelium inthe early mutant em- 
bryo by morphology and 13-gal staining. These results sug- 
gest that specification of the telencephalic neuroepithel- 
ium does not require BF-I. The mechanisms that initially 
subdivide the forebrain neuroepithelium remain functional 
in the BF-1 mutant. However, BF-1 is essential for the 
normal growth and differentiation ofthe telencephalic neu- 
roepithelium after its positional identity is determined. 
We next examined the mechanism by which BF-1 con- 
trols the growth of the telencephalic neuroepithelium. At 
E9.5, the fraction of cells labeled with a pulse of BrdU in 
the telencephalon of the BF-1 mutant is indistinguishable 
from that of normal embryos. However, by E10.5, we ob- 
serve a dramatic reduction in BrdU-labeled cells in the 
ventral telencephalic neuroepithelium of the mutant. To- 
gether with the I~-gal expression results, these data sug- 
gest that, although telencephalic neuroepithelial cells in 
the BF-1 mutant are initially able to proliferate after they 
are specified, abnormalities in cell proliferation develop 
soon thereafter. We conclude that BF-1 is essential for 
the continued proliferation of the ventral telencephalic 
neuroepithelium after E9.5. The mutant dorsal telence- 
phalic neuroepithelium appears to proliferate normally for 
a longer period of time; however, by E12.5 we observe 
areas of diminished BrdU labeling interspersed with areas 
of apparently normal fractions of labeled cells. We also find 
an abnormally wide zone of cells outside of the cerebral 
cortical ventricular zone that expresses MAP2 and does 
not label with BrdU, suggesting that cells of the dorsal 
telencephalic neuroepithelium are prematurely leaving 
the cell cycle and beginning to differentiate arlier than 
usual. Thus, proliferation of the dorsal telencephalic neu- 
roepithelium is altered in the BF-1 mutant, but at a later 
developmental stage than in the ventral neuroepithelium. 
We propose that the resulting early depletion of the pro- 
genitor cell population in the dorsal telencephalic neuro- 
epithelium is the primary basis for the small size of the 
dorsal telencephalon in the BF-1 mutant. 
The nonuniform consequences of the BF-1 deletion on 
the growth and development of the telencephalon might 
seem to be inconsistent with the uniform expression of 
BF-1 in the telencephalon. Whereas the ventral telenceph- 
alon fails to grow appreciably after E9.5, the dorsal telen- 
cephalon does grow, albeit not nearly to normal size. We 
suggest two interpretations for the apparently different ef- 
fects of the BF-1 mutation on dorsal and ventral telenceph- 
alon development. First, it is possible that the BF-1 expres- 
sion pattern does not reflect its function. BF-1 may have 
different functions in the dorsal and ventral regions of tel- 
encephalon. It may be that measurements of BF-1 mRNA 
levels do not reflect the levels in BF-1 protein expression, 
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or that different forms of the protein are expressed. How- 
ever, the three different BF-1 transcripts we find in brain 
all encode the same protein (H. Li and E. L., unpublished 
data). Different functions of BF-1 in dorsal and ventral tel- 
encephalon may be due to interactions with regionally re- 
stricted molecules that modulate its activity. For example, 
a ventral telencephalon-specific coactivator may enhance 
the activity of BF-1 in the ventral telencephalon, thus ac- 
counting for a more severe ventral phenotype in the BF-1 
mutant. 
We favor a second possible interpretation of the data, 
which postulates a common function for BF-1 throughout 
the telencephalon in promoting cell proliferation. The dor- 
sal and ventral regions of the telencephalon ormally differ 
in their proliferative potential as well as in the timing of 
neuronal differentiation. The dorsal telencephalic neuro- 
epithelium has a delayed onset of neuronal differentiation 
compared with that of the ventral region, which leads to 
a longer period of neuroepithelial cell proliferation and 
greater growth of the dorsal telencephalon (Altman and 
Bayer, 1995). We believe that these features and the phe- 
notype of the BF-1 deletion both suggest that BF-1 is not 
the sole regulator of cell proliferation in the developing 
telencephalon. In our model, BF-1 does not control the 
differential growth of the dorsal versus ventral telencepha- 
Ion, but rather it functions to enhance the growth of the 
entire telencephalon. Although BF-1 is essential for neuro- 
epithelial cells of the ventral telencephalon to proliferate, 
dorsal neuroepithelial cells must contain additional inde- 
pendent regulators that enable them to proliferate to a 
limited degree in the absence of BF-I. It is possible that 
regulators of proliferation are also restricted to subregions 
of the dorsal telencephalon, thus accounting for the subtle 
variations in cell proliferation found within this region. Dor- 
sal-specific transcription factors such as Emxl and Emx2 
are candidates to be independent regulators of prolifera- 
tion in the dorsal telencephalic neuroepithelium. Thus, we 
believe that normal regional differences in the growth of 
the telencephalon can be attributed to the combinatorial 
action of independently acting regulators of proliferation. 
Cytokinetic studies of neuorepitnelial cells have demon- 
strated a progressive increase in cell cycle length in the 
cerebral cortical region during the period of neuronal dif- 
ferentiation (El 1-E17) in the mouse. This increase is due 
largely to an increase in the length of G1 (Hoshino et al., 
1973). These changes are associated with an increase in 
the fraction of cells exiting the cell cycle and with depletion 
of the cerebral cortical neuroepithelium (Takahashi et al., 
1992). The normal decline in the expression levels of BF-1 
during the period of neurogenesis may control the progres- 
sive depletion of the cerebral cortical neuroepithelium in 
normal development. Thus, we postulate that BF-1 nor- 
mally functions to enhance cell proliferation by facilitating 
cell cycle progression. Such a function for BF-1 is reminis- 
cent of the activities of mitogens. We suggest that BF-1 
may act by enhancing the response of neuroepithelial cells 
to mitogenic signals or, more directly, by regulating the 
activity of the components of the cell cycle machinery. 
These actions of BF-1 ultimately control the size of the 
telencephalon relative to the rest of the CNS. It is tempting 
to speculate that changes in the activity of BF-1 may be 
implicated in the encephalization of the brain during evo- 
lution. 
Winged Helix Transcription Factors 
and Morphogenesis 
While major advances have been made in identifying the 
genes specifying positional information in the early em- 
bryo, our understanding of how this information is trans- 
lated into the control of morphogenesis remains limited. 
An essential component of morphogenesis is the precise 
regulation of the rate and duration of the proliferation of 
progenitor cells. Our studies of the BF-1 mutant strongly 
implicate this gene in the control of the proliferation and 
timing of differentiation of neuroepithelial precursor cells 
of the telencephalon. A large number of transcriptional 
regulators, including many WH genes, have been de- 
scribed with highly restricted patterns of expression during 
embyrogenesis. While transcription factors with restricted 
patterns of expression in adult tissues are usually associ- 
ated with the regulation of tissue-specific genes, such fac- 
tors may have different roles during development. Our 
results support a model in which morphogenesis is con- 
trolled through the combined actions of multiple transcrip- 
tional regulators with highly restricted expression pat- 
terns. We suggest that these factors regulate common 
targets that control cell division, thereby establishing tem- 
poral and spatial control of cell proliferation. A similar para- 
digm has been described from the studies of string func- 
tion and regulation during Drososphila development. Cell 
proliferation in the early embryos is regulated by expres- 
sion of string, which encodes a cdc25-type phosphatase 
that activates cdc2 (Edgar and O'Farrell, 1989; Millar and 
Russell, 1992). Recent studies show that many known 
patterning genes act locally to influence string expression 
and thereby control cell cycle progression (Edgar et al., 
1994). Similar developmental control of the G1-S transi- 
tion through the regulation of the expression of cyclin E 
has also been described (Duronio and O'Farrell, 1994; 
Knoblich et al., 1994). In mammals, Hoxgenes have been 
postulated to provide region-specific regulation of the local 
growth of precursor cells based on the morphogenetic on- 
sequences of targeted gene disruptions (Dolle et al., 1993; 
Condie and Capecchi, 1994). Thus, we speculate that 
BF-1 and other WH factors may translate positional infor- 
mation into the control of morphogenesis by indepen- 
dently regulating the expression of components of the cell 
cycle machinery in selected sets of progenitor cells. The 
activity of WH transcription factors could therefore serve 
to control the size of different structures and organs by 
controlling the number and timing of cell divisions in the 
precursor cells. 
Experimental Procedures 
Targeting of the BF-1 Locus and Generation of Homozygous 
BF-1 (-/-) Animals 
Genomic 129/Ola clones containing the entire BF-1 gene were isolated 
from a ZGEM library (provided by A. Berns). Restriction endonuclease 
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and partial sequence analysis were used to identify the BF-1 coding 
sequence. The targeting vector was constructed by fusing a/acZ cas- 
sette containing an intren to an Ncol site encoding amino acid 13 (Met) 
of the BF-1 coding sequence. This site had been previously generated 
by site-directed mutagenesis in a SalI-Kpnl genomic fragment con- 
taining the BF-1 transcription initiation site. The PGK-neo cassette 
from the plasmid pKJ1 (M. McBurney; Tybulewicz et al., 1991), which 
contains the neomycin resistance gene (neo) under the control of the 
phosphoglycerate kinase (PGK) pro moter was then ligated to the 3'end 
of the lacZ cassette. The SmaI-Ndel fragment from the 3' untranslated 
sequence of the BF-I cDNA was ligated to the 3' end of the PGK-neo 
cassette. The entire fragment with a 5' Sail and 3' Xhol site was then 
cloned at the Sail site into a pGEM4 plasmid containing the BamHI- 
Sail BF-1 genomic fragment. The 5' BamHI site was previously 
changed to an Sfil site with linkers, to provide a unique site for lineariza- 
tion of the plasmid. 
We used both C J7 (Swiatek and Gridley, 1993) and J1 (Lee et al., 
1992) ES cells, generously provided by Drs. T. Gridley and R, Jaenisch, 
respectively. Recombinant ES cells were generated essentially as de- 
scribed previously (Swiatek and Gridley, 1993). Briefly, 107 ES cells 
were electroporated with 30 I~g of linearized targeting vector using a 
Bio-Rad Gene Pulser (250 ~F; 250 V). Cells were then plated into 10 
cm tissue culture dishes at a density of 5 × 105 cells per dish. G418 
(Geneticin, GIBCO) selection was applied 24 hr after transfection at 
250 lig/ml, and resistant colonies were isolated after 7-8 days. Disag- 
gregated colonies were plated into wells of 96-well plates containing 
embryonic flbroblast feeder cells. Two-thirds of the cells were plated 
for PCR screening, and one-third were plated for future expansion. 
All the cells were grown in G418 selection media. Resistant clones 
were analyzed by PCR as described (LeMouellic et al., 1990) with 
the PGK primer 5'-AGTATTG I I I I GCCAAGTTCTAAT-3'and the BF-1 
primer 5'-TCCTATAAGTTGAATGGTA I I t l G-3'. Approximate primer 
positions are indicated in Figure 1A. These primers yield a product of 
1.1 kb with homologous recombinants. PCR was carried through 40 
cycles at 94°C for 15 s, 55°C for 30 s, and 72°C for 1 rain. Positive 
clones by PCR were expanded for karyotype analysis, genomic South- 
ern analysis, and injection into blastocysts. We obtained a total of 10 
correctly targeted lines from 950 G418-resistant clones. 
ES cell colonies positive for homologous recombination at the BF-1 
locus were resuspended in injection medium (DMEM with 10 mM 
HEPES buffer and 10O/o fetal bovine serum). ES cells (10-15) were 
injected into the blastocoel cavity of 3.5 days postcoitum blastocysts 
isolated from C57BL/6J female mice. The injected blastocysts were 
then implanted back into the uteri of pseudopregnant B6CBAFI/J or 
CD1 (Jackson Laboratories) females at 2.5 days postcoitum. The re- 
sulting male chimeras with extensive ES cell contribution to the coat 
were bred with C57BL/6J females, and germline transmission was 
identified initially by the presence of agouti progeny. Mice heterozy- 
gous for the BF-1 mutation were intercrossed to generate homozygous 
BF-1 ( - / - )  animals. 
Genotyping by Southern Analysis and PCR 
Genomic DNA was obtained from ES cells, mouse tail tips, and embry- 
onic sacs as previously described (Hogan et al., 1986; Bonnerot and 
Nicolas, 1993). Southern blot analysis was performed to confirm that 
the correct homologous recombination event, with the replacement 
of the BF-1 coding sequence, had occurred. Genomic DNA (7-8 ~g) 
was digested with the restriction enzymes BamHI or Kpnl. DNA was 
blotted onto Zeta-Probe GT membranes (Bio-Rad). Hybridization and 
washing was carried out according to the manufacturer's instructions. 
Membranes were hybridized to three probes: one 5' to the targeted 
sequence (KpnI-Hindlll BF-1 genomic fragment), one 3'to the targeted 
sequence (SmaI-Ndel BF-1 genomic fragment), and one to the/acZ 
DNA (EcoRI-ECORV fragment), 
Routine genotyping of mice was performed by PCR. Primer se- 
quences for BF-1 were BF1-U (5'-GGGCAACAACCACTCCTTCTC- 
CAC-3') and BF1-L (5'-GACCCCTGATTTTGATGTGTGAAA-3~. The 
expected size of the BF-1 product was 295 bp. We also used previously 
described primers to identify the lacZ gene (Bonnerot and Nicolas, 
1993). PCR cycling conditions were 94°C for 15 s, 60°C for 30 s, and 
72°C for 90 s, for a total of 30 cycles. 
Histology and I}-gal Staining 
Embryos were obtained from timed pregnancies, with noon of the plug 
date defined as E0.5. Embryos were fixed in 4% paraformaldehyde. 
E16.5 and older embryos were perfusion-fixed by cardiac puncture. 
Paraffin embedding was performed by dehydrating embryos through 
ethanol and Histoolear (National Diagnostics) prior to immersion in 
paraplast (Fisher Scientific). Sections of 8 p.m were stained with hema- 
toxylin and eosin. 
B-gal staining in 10 I~m cryostat sections and whole embyros was 
performed as previously described (Bonnerot and Nicolas, 1993). Sec- 
tions were stained for 2-8 hr and counterstained with Nuclear Fast 
Red. Whole embryos were stained for 30 min to 24 hr. Heterozygous 
specimens were stained for twice as long as homozygous pecimens 
to compensate for the number of copies of ~-gal. Selected stained 
whole embryos were subsequently embedded in paraffin for sectioning 
and counterstaining with Nuclear Fast Red. 
In Situ Hybridization 
Embryos were fixed in 4% paraformaldeyde and embedded in paraffin. 
Sections (8 pm) were processed for in situ hybridization with digoxi- 
genin-labeled probes as previously described, except for the following 
changes (Schaeren-Wiemers and Gerfin-Moser, 1993). Digoxigenin- 
labeled cRNA probes (15 nM) were hybridized at 58°C. Anti- 
digoxigenin antibody (Boehringer Mannheim) diluted to 1:5000 was 
incubated with the tissue overnight. Probe templates were kindly pro- 
vided by E. Boncinelli (Emxl and Emx2; Simeone et al., 1993), P, 
Gruss (Pax6; Walther and Gruss, 1991), and J. Rubenstein (Dlxl and 
DIx2; Porteus et al., 1991). 
BrdU Incorporation and Immunohistochemietry 
For immunohistochemical detection of BrdU (Gratzner, 1982), BrdU 
(Sigma) was injected intraperitoneally into pregnant mice (30 mg/kg) 
2 hr before sacrifice. Embryos were fixed in 4% paraformaldehyde 
for 4 hr and embedded in paraffin. Sections (8 lim) were treated with 
5 i~g/ml proteinase K at 37°C for 10 min, followed by denaturation of 
the DNA in 1 N HCI at 55°C for 10 min. After washing in PBS, sections 
were immersed in 0.1% H202 in PBS. Sections were then treated with 
avidin and biotin blocking solutions (Vector Laboratories) prior to 
blocking with 100/o normal rabbit serum in PBS containing 0.5% Triton 
X-100 (PBS-TX). Sections were then incubated at 4°C overnight with 
rat monoclonal anti-BrdU antibody (clone Bl/75; Sera Lab) diluted 
1:50 in PBS-TX with 1% normal rabbit serum. The following day sec- 
tions were incubated with biotinylated rabbit anti-rat antibodies diluted 
1:200 in PBS with 1.5% normal rabbit serum for 30 min at room temper- 
ature, followed by incubation with avidin conjugated with peroxidase 
for 30 min at room temperature. Peroxidase reaction was developed 
with diaminobenzidine and H2Oz (Sigma) in PBS. Sections were coun- 
terstained lightly with hematoxylin. 
For MAP2 immunohistochemistry, sections were blocked with 10% 
normal goat serum (Jackson immunoResearch Labs) in PBS-TX and 
then incubated at 4°C overnight with mouse monoclonal anti-MAP2 
antibodies (clone HM-2; Sigma) diluted 1:250 in PBS-TX with lO/o 
normal goat serum. Sections were then incubated with goat anti- 
mouse antibodies conjugated with peroxidase (Jackson ImmunoRe- 
search Labs) diluted 1:50 in PBS-TX with 1% normal goat serum. 
Sections were then processed as above. 
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